Mold-Tek Packaging Ltd

- No additional debt is expected for capacity expansion in FY '27; internal accruals will fund capex. - Planned capital expenditure for FY '27 is around INR 80-85 crores, mostly funded from internal cash generation. - Cash generation this year is around INR 100 crores net after dividend, sufficient for planned capex and debt repayment. - Debt repayment will happen from cash accruals, and overall debt is not expected to increase. - No mention of new equity fundraising or share issuance in the provided transcript. - The company focuses on brownfield expansions with limited capital needs going forward.

- Planned capital expenditure for FY '27 is around INR 80-85 crores, primarily funded through internal accruals; no significant additional debt expected. - Focus on brownfield expansions mainly at Mysore and Satara (Mahad plant supply). - Addition of 4 new thin wall machines at Panipat in July, doubling thin wall capacity, aiming to increase capacity utilization from 20-25% to 40-50% next year. - New land acquired near Sultanpur for a Pharma plant; construction expected to start soon after land possession, with commercial production targeted by the end of FY '27 (possibly January 2028). - Consolidation of Hyderabad plants from 5 to 2 units to improve efficiency and reduce overheads. - Continued investments to support growth in Pharma packaging and sustainable capacity utilization crossing 70% from next year onwards.

- Volume growth for FY '27 is expected to be between 10% to 13%, primarily because Pharma volumes will remain low despite high value growth. - Value growth guidance for FY '27 is 13% to 15%, driven by higher realizations and client additions, especially in Food, FMCG, Paints, and ABG segments. - The Lubricant segment is expected to remain stagnant with no major volume growth. - Asian Paints and ABG are key growth drivers, with Asian Paints expected to improve from ~3.5% annual growth to around 10% in FY '27. - Food and FMCG, especially from the North (Panipat) plant, are anticipated to grow at around 20%. - EBITDA per kg is targeted to improve to 42.5 in FY '27 and 43-44 in FY '28 due to operational efficiencies. - Revenue is expected to cross INR 1,000 crores in FY '27, with a target to surpass INR 1,200 crores by FY '28.

- Targeting at least INR 210 crores EBITDA in FY 2026-27, up from INR 173 crores, indicating ~20% growth. - Aiming for 13%-15% value growth and 10%-13% volume growth in FY 2026-27. - EBITDA per kg expected to improve to 42.5 in FY 2026-27 from 40.7 in FY 2025-26, with potential to reach 43-44 in FY 2027-28. - ROCE expected to rise from 12.4% to around 13.5%-14% in FY 2026-27, possibly reaching 15% by FY 2027-28. - Profitability gains driven by increased business, operational efficiencies, consolidation of plants, and capacity utilization growth (70%+ expected in FY 2026-27). - No major downside expected barring unforeseen events like war impact; prospects could be better than guided. - Revenue expected to cross INR 1,000 crores in FY 2026-27 and potentially INR 1,200 crores by FY 2027-28.

The transcript provided does not explicitly mention the current or expected order book or pending orders for Mold-Tek Packaging Limited. However, some relevant points related to order inflows and customer additions can be inferred: - New clients have been onboarded at the Panipat facility, especially in FMCG/thin wall packaging, contributing to increasing volumes. - Recent signing of a couple of big clients in the North region who were previously buying from competitors. - Existing large clients like Asian Paints, ABG, and HUL are maintaining or increasing their demand. - Growth in Paints segment volumes driven largely by ABG and Asian Paints. - Pharma segment demand is growing on replacement demand and export recovery. - Pharmaceutical packaging products are under development, with commercial revenues expected to start adding in 2-3 quarters. No specific orderbook numbers or pending orders data are disclosed.